These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 29196221)
1. Characterisation of methicillin-resistant Staphylococcus aureus with reduced susceptibility to ceftaroline collected in Russia during 2010-2014. Gostev V; Kalinogorskaya O; Kruglov A; Lobzin Y; Sidorenko S J Glob Antimicrob Resist; 2018 Mar; 12():21-23. PubMed ID: 29196221 [No Abstract] [Full Text] [Related]
2. Non-susceptibility to ceftaroline in healthcare-associated multiresistant MRSA in Eastern Australia. Mubarak N; Sandaradura I; Isaia L; O'Sullivan M; Zhou F; Marriott D; Iredell JR; Harkness J; Andresen D J Antimicrob Chemother; 2015 Aug; 70(8):2413-4. PubMed ID: 25977400 [No Abstract] [Full Text] [Related]
3. Reduced In Vitro Activity of Ceftaroline by Etest among Clonal Complex 239 Methicillin-Resistant Staphylococcus aureus Clinical Strains from Australia. Abbott IJ; Jenney AW; Jeremiah CJ; Mirčeta M; Kandiah JP; Holt DC; Tong SY; Spelman DW Antimicrob Agents Chemother; 2015 Dec; 59(12):7837-41. PubMed ID: 26392488 [TBL] [Abstract][Full Text] [Related]
4. Impact of EUCAST, CLSI and USCAST ceftaroline breakpoint changes on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from US medical centres (2015-2018). Sader HS; Jones RN Clin Microbiol Infect; 2020 May; 26(5):658-659. PubMed ID: 31899333 [No Abstract] [Full Text] [Related]
5. In vivo emergence of ceftaroline resistance during therapy for MRSA vertebral osteomyelitis. Sanchez EH; Mendes RE; Sader HS; Allison GM J Antimicrob Chemother; 2016 Jun; 71(6):1736-8. PubMed ID: 26861570 [No Abstract] [Full Text] [Related]
6. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model. Zhanel GG; Rossnagel E; Nichol K; Cox L; Karlowsky JA; Zelenitsky S; Noreddin AM; Hoban DJ J Antimicrob Chemother; 2011 Jun; 66(6):1301-5. PubMed ID: 21429940 [TBL] [Abstract][Full Text] [Related]
7. In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolates Collected in 2012 from Latin American Countries as Part of the AWARE Surveillance Program. Biedenbach DJ; Hoban DJ; Reiszner E; Lahiri SD; Alm RA; Sahm DF; Bouchillon SK; Ambler JE Antimicrob Agents Chemother; 2015 Dec; 59(12):7873-7. PubMed ID: 26416860 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus isolates. Basireddy S; Singh M; Ali S; Kabra V Indian J Med Microbiol; 2015; 33(3):464-5. PubMed ID: 26068368 [No Abstract] [Full Text] [Related]
9. Activity of ceftaroline against community associated and healthcare associated methicillin resistant Staphylococcus aureus. Coombs GW; Pearson JC; Robinson JO; Christiansen KJ Pathology; 2014 Jan; 46(1):71-3. PubMed ID: 24300719 [No Abstract] [Full Text] [Related]
10. [Evaluation E-test method to determine the antimicrobial activity of ceftaroline against methicillin-resistant strains of Staphylococcus aureus]. Tenorio-Abreu A; Ávila A; Gil J; Ortiz de Lejarazu R; Colomina J Rev Esp Quimioter; 2014 Dec; 27(4):279-80. PubMed ID: 25536434 [No Abstract] [Full Text] [Related]
11. In vitro activity of ceftaroline and ceftobiprole against methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin isolated in paediatric patients. Carnesecchi G; Lobello R; Liggieri L; Palmero C; Pescetto L; Morelli P; Castagnola E; Bandettini R J Chemother; 2018; 30(6-8):338-341. PubMed ID: 30375268 [TBL] [Abstract][Full Text] [Related]
12. In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program. Biedenbach DJ; Alm RA; Lahiri SD; Reiszner E; Hoban DJ; Sahm DF; Bouchillon SK; Ambler JE Antimicrob Agents Chemother; 2016 Jan; 60(1):343-7. PubMed ID: 26503659 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals. Andrey DO; François P; Manzano C; Bonetti EJ; Harbarth S; Schrenzel J; Kelley WL; Renzoni A Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):343-350. PubMed ID: 27744604 [TBL] [Abstract][Full Text] [Related]